CVS Health Corporation $CVS Shares Sold by Parkwood LLC

Parkwood LLC reduced its holdings in shares of CVS Health Corporation (NYSE:CVS) by 9.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 164,882 shares of the pharmacy operator’s stock after selling 17,127 shares during the quarter. Parkwood LLC’s holdings in CVS Health were worth $17,057,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in CVS. Caitong International Asset Management Co. Ltd increased its holdings in CVS Health by 407.2% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 281 shares in the last quarter. Swiss RE Ltd. purchased a new stake in shares of CVS Health during the fourth quarter valued at approximately $26,000. Kilter Group LLC acquired a new position in shares of CVS Health during the second quarter worth $27,000. Sankala Group LLC acquired a new stake in CVS Health during the 4th quarter valued at $28,000. Finally, Global Trust Asset Management LLC lifted its holdings in CVS Health by 344.8% in the 1st quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 300 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on CVS shares. Argus lifted their target price on CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a research report on Wednesday, August 19th. JPMorgan Chase & Co. lifted their price target on shares of CVS Health from $111.00 to $118.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Wall Street Zen raised shares of CVS Health from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 8th. Sanford C. Bernstein upped their price objective on CVS Health from $94.00 to $106.00 and gave the company an “outperform” rating in a research note on Tuesday, May 12th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on CVS Health from $88.00 to $92.00 and gave the company a “buy” rating in a research report on Thursday, May 7th. Twenty-two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $107.17.

CVS Health Price Performance

Shares of NYSE:CVS opened at $94.22 on Thursday. The stock’s 50 day moving average price is $101.63 and its 200 day moving average price is $89.33. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The stock has a market cap of $120.50 billion, a price-to-earnings ratio of 24.93, a PEG ratio of 0.84 and a beta of 0.61. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business had revenue of $106.10 billion during the quarter, compared to analysts’ expectations of $100.03 billion. During the same quarter last year, the business posted $1.81 earnings per share. The company’s quarterly revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Equities research analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a $0.665 dividend. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. CVS Health’s dividend payout ratio (DPR) is 70.37%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.